Related Experiment Videos

B7-1 gene-modified tumor cell vaccines

¹University of South Florida, Division of Medical Oncology, H Lee Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USA. antonias@moffitt.usf.edu

Current Opinion in Molecular Therapeutics

|March 16, 2001

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Phase I study of peposertib and avelumab with or without palliative radiotherapy in patients with advanced solid tumors.

ESMO open·2024

A single-arm, multicenter, phase II trial of osimertinib in patients with epidermal growth factor receptor exon 18 G719X, exon 20 S768I, or exon 21 L861Q mutations.

ESMO open·2023

Outcomes with durvalumab after chemoradiotherapy in stage IIIA-N2 non-small-cell lung cancer: an exploratory analysis from the PACIFIC trial.

ESMO open·2022

Clinical definition of acquired resistance to immunotherapy in patients with metastatic non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

See all related articles